Global Equity Flows Chasing Momentum Over Value Analyst Anurag Singh Observes
Life Time Group LTH Positioned as a Potential Leader in the Health and Fitness Sector
Mercury Valuation Soars to 52 Billion in Latest Funding Round Marking 49 Increase in 14 Months
Amid Conflict Israeli and Arab Entrepreneurs Forge Economic Partnerships
Billionaire Investor John Doerr Says AI Revolution Remains Underhyped Despite Years of Frenzy
Russia Warns of Systematic Kyiv Strikes Escalating Geopolitical Risk for Global Markets
DORM Q1 2026 Earnings EPS Misses Estimates Amid Challenging Operating Environment
General Dynamics Q1 2026 Earnings Strong EPS Beat Drives Positive Market Reaction
FULTP Q1 2026 Earnings Preferred Stock Reports EPS Beat Amid Steady Performance
CrossAmerica Partners LP CAPL Q1 2026 Earnings Strong Earnings Surprise Offsets Missing Revenue Data
CETY Q4 2024 Earnings Net Loss of 002 Per Share as Clean Energy Firm Navigates Growth Phase
DEFSEC Technologies Inc DFSC Q2 2024 Earnings EPS Misses Estimates Stock Rises on Strategic Outlook
Adams Natural Resources Fund PEO Holds Steady Near Support as Energy Sector Stabilizes
Agriculture Natural Solutions Acquisition Warrant ANSCW Holds Flat at 023 Amid Low Volume
Gladstone Investment Notes GAING Hold Steady at 2532 as Market Awaits Rate Clarity
IsoEnergy Ltd ISOU Rallies Over 3 as Uranium Sector Sees Renewed Interest
CPS Technologies CPSH Surges 127 on High Volume Testing Key Resistance at 552
Streaming Platforms Gear Up for Weekend Content Drop Netflix Hulu Prime Video Apple TV and More Unveil New Releases
ixigo Partners with Uber and redBus to Integrate Cab and Bus Booking into Train App
TikTok and YouTube Face Scrutiny Over Child Safety Standards by UK Regulator Ofcom
Standard Chartered CEO Apologizes for Lower Value Human Capital Remark
Overlooked Dividend King Industrial Sectors Hidden Gem May Offer LongTerm Value
Reddit Shares Tumble as Meta Launches Standalone Facebook Groups App Forum
Unifirst Q1 2026 Earnings EPS Beats Estimates by 212 Modest Stock Uptick
KalVista Pharmaceuticals KALV Holds Steady Near Support After Modest Gain